Artificial nucleic acid molecules encoding a norovirus antigen and uses thereof

US11141474B2 · kind B2 · utility

Assignee

• CureVac AG · DE

Inventors

• Susanne RAUCH · Tübingen, DE
• Kim Ellen SCHWENDT · Dettenhausen, DE
• Benjamin PETSCH · Tübingen, DE

Key dates

• Filing date: May 4, 2017
• Grant date: Oct 12, 2021
• Expiry date: Aug 5, 2037

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12N2770/16034
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention is directed to an artificial nucleic acid and to polypeptides suitable for use in treatment or prophylaxis of an infection with Norovirus or a disorder related to such an infection. In particular, the present invention concerns a Norovirus vaccine. The present invention is directed to an artificial nucleic acid, polypeptides, compositions and vaccines comprising the artificial nucleic acid or the polypeptides. The invention further concerns a method of treating or preventing a disorder or a disease, first and second medical uses of the artificial nucleic acid, polypeptides, compositions and vaccines. Further, the invention is directed to a kit, particularly to a kit of parts, comprising the artificial nucleic acid, polypeptides, compositions and vaccines.